March 2017

The latest from Cogstate, leaders in optimizing the measurement of cognition

Cogstate Strengthens Executive Team with Appointment of Chief Technology Officer

March 15, 2017

New Haven, CT – March 15, 2017: The cognitive science company, Cogstate Ltd (ASX.CGS) announced today that Richard Gleeson has joined the senior leadership team as Chief Technology Officer, strengthening the company’s ability to deliver transformative innovations to optimize the measurement of cognition in clinical trials and healthcare. Reporting directly to Cogstate Chief Operating Officer, […]

AMPAR Potentiators May Have Role In The Treatment Of The Cognitive Symptoms Associated With Schizophrenia

March 15, 2017

Treating schizophrenia involves not only addressing the primary positive and negative symptoms but also the frequent cognitive dysfunction that accompanies the disorder, known as cognitive impairment associated with schizophrenia (CIAS). These deficits in attention, working memory and executive function have a detrimental impact on a patient’s quality of life and their functional capacity to manage […]